Literature DB >> 22478938

Pulmonary Infection Due to Mycobacterium malmoense in a Patient with Crohn Disease.

Cory D Cowan1, John J Hawboldt, Mazen Bader.   

Abstract

Entities:  

Year:  2009        PMID： 22478938      PMCID： PMC2827011          DOI： 10.4212/cjhp.v62i6.848

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  17 in total

1.  Mycobacterium malmoense infections in immunocompetent patients.

Authors:  R Enzensberger; K P Hunfeld; M Krause; S Rüsch-Gerdes; V Brade; B Böddinghaus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-08       Impact factor: 3.267

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Mycobacterium malmoense infections in Scotland: an increasing problem.

Authors:  A J France; D T McLeod; M A Calder; A Seaton
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

Review 4.  Lung disease due to the more common nontuberculous mycobacteria.

Authors:  Stephen K Field; Robert L Cowie
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

5.  Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment.

Authors: 
Journal:  Eur Respir J       Date:  2003-03       Impact factor: 16.671

6.  Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.

Authors:  J Banks; P A Jenkins; A P Smith
Journal:  Tubercle       Date:  1985-09

7.  Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations.

Authors:  S E Hoffner; U Hjelm; G Källenius
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Mycobacterium malmoense infections in the United States, January 1993 through June 1995.

Authors:  U T Buchholz; M M McNeil; L E Keyes; R C Good
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

9.  First Canadian Reports of Cervical Adenitis Due to Mycobacterium Malmoense and a 10-year Review of Nontuberculous Mycobacterial Adenitis.

Authors:  Chris McCrossin; Tim Mailman
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

10.  Pulmonary disease due to Mycobacterium malmoense.

Authors:  N G Warren; B A Body; V A Silcox; J H Matthews
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948
View more
  2 in total

1.  Pulmonary Cavity From Mycobacterium malmoense in an HIV-Infected Patient: Complicated by Bronchopleural Fistula.

Authors:  Eric Abston; Harrison Farber
Journal:  Open Forum Infect Dis       Date:  2018-01-24       Impact factor: 3.835

2.  Mycobacterium malmoense: an unusual pathogen causing endocarditis, a case report and literature review.

Authors:  Iván Posso-Osorio; Alejandra De Las Salas; Gabriel J Tobón; Melibea Sierra-Ruiz; Carlos A Cañas; Juan Carlos Bravo; Pablo A Moncada
Journal:  IDCases       Date:  2020-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.